Covishield

Getting A Covaxin Or Covishield Shot? List Of Possible Mild Side Effects

India News | NDTV News Desk | Tuesday March 2, 2021

Phase 2 of the vaccination drive against the coronavirus - in which people aged above 60 and those above 45 with comorbidities are being inoculated - began on Monday.

"Proud To Take The Jab": What Natasha Poonawalla Said On Serum Institute's Covishield

India News | Reported by Sukirti Dwivedi, Edited by Shylaja Varma | Tuesday March 2, 2021

Natasha Poonawalla, Serum Institute of India's Executive Director, was today vaccinated against COVID-19. She received the first shot of Covishield which is manufactured by her company and developed by AstraZeneca and Oxford University.

Sri Lanka May Not Use China Vaccine, Orders 13.5 Million Doses From India

India News | Press Trust of India | Tuesday February 23, 2021

Sri Lanka has ordered 13.5 million Oxford AstraZeneca coronavirus vaccines in addition to the 500,000 doses gifted by India, and the country may not use Chinese vaccines in the second phase of immunisation, a government spokesman said today.

Nepal Gets 1 Million Doses Of COVID-19 Vaccine Bought From India

India News | Press Trust of India | Sunday February 21, 2021

Nepal on Sunday received the one million doses of Covishield vaccine it bought from India's Serum Institute, in a major boost to the country's fight against the COVID-19 pandemic.

"Please Be Patient": Adar Poonawalla To Nations Waiting For Vaccines

India News | Reported by Vishnu Som, Edited by Swati Bhasin | Sunday February 21, 2021

World's biggest vaccine maker Serum Institute of India's Adar Poonawalla this morning urged the nations to "be patient" amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.

On Plea To Declare Covishield "Unsafe", High Court Notice To Centre

India News | Reported by J Sam Daniel Stalin, Edited by Swati Bhasin | Saturday February 20, 2021

The Madras High Court has issued a notice to the central government over a petition to declare the Pune-based Serum Institute of India's "Covishield" unsafe.

"Not One Death Reported Due To COVID-19 Vaccination": Harsh Vardhan

India News | ANI | Tuesday February 16, 2021

Union Health Minister Harsh Vardhan on Monday said no death had been reported due to COVID-19 vaccination and no new cases of COVID-19 have been reported in 188 districts of the country in the last seven days.

India Dispatches Coronavirus Vaccines To Barbados, Dominica

India News | ANI | Monday February 8, 2021

India on Sunday dispatched two consignments of Covishield COVID-19 vaccines to the countries of Barbados and Dominica under the Vaccine Maitri initiative.

165 Lakh COVID-19 Vaccine Doses Procured So Far At Cost Of Rs 350.25 Crore: Centre

India News | Press Trust of India | Friday February 5, 2021

A total of 165 lakh doses of COVID-19 vaccines - Covishield and Covaxin - have been procured so far at a cost of Rs 350.25 crore, Minister of State for Health Ashwini Choubey told Lok Sabha on Friday.

India's Serum Institute Inks UN Deal For 1.1 Billion Covid Vaccines To 100 Countries

India News | Press Trust of India | Thursday February 4, 2021

The Serum Institute of India (SII) and UNICEF have entered into a long-term supply agreement for the AstraZeneca-Oxford 'Covishield' and the Novavax vaccines, with the UN children's agency saying it will have access to up to 1.1 billion doses of vaccines for around 100 countries.

Russian Covid Vaccine Sputnik Could Be Available In India By April: 10 Points

India News | Reported by Vishnu Som | Thursday February 4, 2021

Russian-made Coronavirus vaccine Sputnik -- peer-reviewed by the Lancet Medical Journal -- is undergoing trials in India and could be available for use soon. "I believe the vaccine should be available in India from March- April," Deepak Sapra, the chief of API and pharma services at Dr Reddy's Laboratories, which is manufacturing the vaccine, told...

Court Rejects Move To Stop "Covishield" Trademark Use By Serum Institute

India News | Reported by Vishnu Som, Edited by Debanish Achom | Saturday January 30, 2021

Drug company Cutis Biotech's move to stop the Serum Institute of India from using the trademark "Covishield" has been rejected by a civil court in Pune, the Serum Institute's lawyers said in a note to the media.

No Adverse Reactions Of Indian COVID-19 Vaccines So Far: Sri Lanka

India News | Press Trust of India | Saturday January 30, 2021

No adverse reactions or side-effects have so far been reported by 5,286 people who were vaccinated in Sri Lanka on Friday with Oxford-AstraZeneca vaccine Covishield, provided by India, health officials said on Saturday.

IOA President Narinder Batra Receives First Dose Of Covid Vaccine

Asian News International | Saturday January 30, 2021

The IOA president Narinder Batra and his family members received first dose of Covishield Vaccine and will take the second dose after four weeks.

Why India Is Exporting Vaccines But Not Selling Them For Public Use

India News | Reported by Vishnu Som, Edited by Anindita Sanyal | Friday January 29, 2021

India has started shipping out millions of doses of Covishield free of cost. On the list are 13 nations -- Bangladesh, Bhutan, Maldives, Mongolia, Myanmar, Nepal, Bahrain, Brazil, Mauritius, Morocco, Oman, Seychelles and Sri Lanka. But while the move improves the country's standing internationally, there are questions why the government is not allo...